Our findings demonstrate the important roles of different HAS types in specific diseases, and suggest that targeting their gene expression or encoded proteins, or designing therapeutic strategies in conjunction with their pathways and associated networks, may be helpful in inhibiting cancer progression. The gene discussed is HAS1; the disease is cancer.